Chitosan scaffolds are an effective biologically active material with versatile application in chemistry and medicine. Chitosan is a linear polysaccharide, a derivative of chitin, with great biocompatibility due to the possession of functional groups such as −OH and −NH 2 , which allow for biodegradability and antibacterial function. Chitosan has a polycation nature allowing complex formation with metal ions and many biomolecules such as DNA, proteins and lipids, while its specific structure and functional groups are responsible for antibacterial, hemostatic, and analgesic properties. To improve its angiogenic and antimicrobial potential, chitosan can be modified by boron (borate ions). The aim of this work was to prepare boric acid modified chitosan scaffolds, using boric acid as a boron precursor, as potential bioactive scaffolds for tissue regeneration. Borate ions tend to form complexes with hydroxyl groups, however, such physical interactions between boron and chitosan functional groups result in poor encapsulation efficiency. To ensure higher boron incorporation, chitosan scaffolds were cross-linked by genipin, a cross linker with lower cytotoxicity in contrast to glutaraldehyde commonly used to prepare stable chitosan-based materials. The degree of deacetylation (DD) and concentration of chitosan solution as well as the concentration of a solvent are important parameters that affect the crosslinking process. Moreover, the addition of boric acid could interfere with the crosslinking process by occupying chitosan functional groups. Here, chitosan scaffolds were modified with different concentrations of boric acid, while the concentrations of chitosan solution (1.2 w/v), genipin (2 % w/w), and acetic acid (0.5 % v/v) were kept constant. Obtained scaffolds were characterised by scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), differential scanning calorimetry (DSC), Fourier transformation infrared spectroscopy (FTIR), while cytotoxicity was evaluated as a function of materials concentration and exposure time. The results indicated successful incorporation of boron into crosslinked chitosan scaffolds with highly porous structure and low cytotoxicity.
Biologically compatible chitosan-based scaffolds have been considered a promising platform for tissue regeneration, tumor treatment, and targeted drug delivery. Chitosan-based scaffolds can be utilized as pH-sensitive drug carriers with targeted drug delivery resulting in less invasive tumor treatments. Further improvement with bioactive ions, such as borate ions, can result in the dual functionality of chitosan carriers provided by simultaneous antitumor efficacy and tissue regeneration. Here, boric acid-containing crosslinked chitosan scaffolds were prepared as delivery systems of doxorubicin, a chemotherapy drug used in the treatment of osteosarcoma. The encapsulation of boric acid was indicated by FTIR spectroscopy, while the ICP-MS analysis indicated the rapid release of boron in phosphate buffer (pH 6.0) and phosphate-buffered saline solution (pH 7.4). The obtained chitosan-boric acid scaffolds exhibit a highly porous and interconnected structure responsible for high swelling capacity, while enzymatic degradation indicated good scaffolds stability during four weeks of incubation at pH 6.0 and 7.4. Furthermore, the release of doxorubicin investigated in phosphate buffers indicated lower doxorubicin concentrations at pH 7.4 with respect to pH 6.0. Finally, the cytotoxicity of prepared doxorubicin-encapsulated scaffolds was evaluated on human sarcoma cells indicating the scaffolds’ potential as cytostatic agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.